NEXIUM
is a proton pump inhibitor (PPI).
NEXIUM delayed-release capsules and NEXIUM for delayed-release oral
suspension are indicated for the:
•
Short-term treatment in the healing of erosive esophagitis (EE) in adults and pediatric patients 12 years to 17 years of age.
•
Maintenance of healing of EE in adults.
•
Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 12 years to 17 years of age.
•
Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults at risk for developing gastric ulcers due to age (60 years and older) and/or documented history of gastric ulcers.
•
Helicobacter pylori eradication in adult patients to reduce the risk of duodenal ulcer recurrence in combination with amoxicillin and clarithromycin.
•
Long-term treatment of pathological hypersecretory conditions, including
Zollinger-Ellison syndrome in adults.
